THE PROBLEM WITH INDIVIDUAL TESTING
Healthcare was built around individuals. Relationships werent.
Patients experiencing recurrent infections, fertility challenges, or unsuccesful treatments are often evaluated one person at a time — even when the answers may be shared.
Partner Health is Shared Health
50%
MEN RESPONSIBLE FOR INFERTILITY
Microbiome imbalance linked to lower sperm count and motility
88%
PREDICTION ACCURACY
A man's penile microbiome can predict BV incidence in his female partner with 88.8% accuracy.
80%
RECURRENT BACTERIAL VAGINOSIS
High recurrence within 3–12 months, often partner-related.
WHY ANTEROS?
What Anteros helps providers do
A complementary layer of insight — not a replacement for existing diagnostic workflows.
Identify sources of reinfection
Uncover partner-related microbial patterns that may explain why symptoms return after treatment.
Support fertility planning
Reproductive microbiome insights for preconception counseling and fertility optimization.
Expand clinical visibility
When standard testing is inconclusive, Anteros helps reveal partner-related contributors.
Improve patient engagement
Education tools and longitudinal tracking designed to support preventive, proactive care.
WHO CAN BENEFIT
The right patients for Anteros
Designed to expand clinical options for providers treating complex or recurring presentations.
RECURRENT INFECTIONS
Patients with recurring BV, UTIs, or vaginal symptoms
Testing both partners may reveal shared microbial patterns that traditional single-patient approaches miss.
fertility & preconception
Patients trying to conceive but not understanding microbiome factors
The reproductive microbiome is increasingly recognized as a key factor in fertility and pregnancy outcomes.
inconclusive testing
Patients with unexplained symptoms
Anteros helps expand the clinical picture beyond the individual patient when workups come back unclear.
preventive care & educational tools
Patients seeking proactive reproductive health insights
Patients increasingly want to understand how lifestyle, sexual activity, and microbiome health influence long-term wellness.
HOW IT WORKS
Simple from order to insight
Five steps — from kit order to results integrated into your care plan. Designed to fit into existing workflows.
01
Order a kit
Providers order directly for patients, or refer patients to Anteros. Individual referrals, bulk ordering, and clinic partnerships available.
02
At-home collection
Both partners collect samples privately at home using clinician-designed collection kits. Step-by-step instructions included.
03
Laboratory analysis
Samples processed in CLIA-certified laboratories using advanced molecular testing methods.
04
Results & insights
Patients receive clear, easy-to-read reports. Providers access clinical summaries and supporting interpretation resources.
05
Personalized next steps
Results integrated into fertility planning, treatment discussions, patient education, and ongoing care management.
WHAT MAKES ANTEROS DIFFERENT
Traditional testing vs. Anteros
A side-by-side view of what changes when both partners health impact is considered.
CATEGORY | TRADITIONAL TESTING | ANTEROS |
|---|---|---|
Sample collection | Clinic visit required | ✓ At-home, both partners |
Patient engagement | Minimal | ✓ Education + behavior support |
Care model | Reactive | ✓ Supports proactive planning |
Partner visibility | Limited to none | ✓ Partner-centered insights |
Testing cadence | Snapshot in time | ✓ Designed for ongoing tracking |
Patient scope | Focuses on one patient | ✓ Evaluates both partners |
Research-driven.Patient-centered.
Our scientific approach is guided by experts across reproductive health, microbiology, fertility, bioinformatics, and women's health. We believe the future of reproductive medicine will move beyond individual diagnostics toward understanding the interconnected biology of partners.
BUILT TO FIT YOUR WORKFLOW
Flexible options for any practice
Anteros is designed to integrate into existing clinical workflows — not create new ones.
Individual referrals
Refer individual patients directly. No clinic partnership required to get started.
clinic partnerships
Formal partnerships with bulk kit ordering, staff education, and co-branded patient materials.
research collaborations
Institutional research partnerships for academic medical centers and clinical investigators.
FREQUENTLY ASKED QUESTIONS
Common provider questions
Does Anteros replace standard clinical testing?
No. Anteros is designed to complement — not replace — existing diagnostic and clinical workflows. Results can be incorporated into broader clinical decision-making.
Can OB-GYN clinics stock or recommend the Anteros Bio kit?
Yes. Anteros Bio offers two clinical partnership models: wholesale stocking (carry the kit in-clinic for patients to purchase directly) and a referral partnership (refer patients via a unique code and receive a commission per completed purchase). Both are designed to require minimal administrative lift from clinical teams.
What clinical evidence supports couples microbiome testing for BV?
A growing body of peer-reviewed research supports partner microbiome involvement in BV recurrence. A 2021 landmark trial (StepUp) found that treating both partners reduced BV recurrence from 63% to 35%. Multiple studies show significant microbiome concordance between monogamous partners, and Frontiers in Cellular and Infection Microbiology demonstrated
that penile microbiome composition predicts new BV episodes in female partners.
Is the Anteros Bio test lab-certified?
Yes. All Anteros Bio tests are analysed by a CLIA (Clinical Laboratory Improvement Amendments), CAP (College of American Pathologists), and CLEP certified laboratory. These are the same certification standards required for clinical diagnostic testing in the United States, ensuring analytical rigour and reliability.
How can your clinic partner with Anteros Bio?
You get a unique referral code or link. You do not need to manage inventory. Anteros Bio handles fulfilment, lab processing, results delivery, and patient support. You also get reference materials to help you talk with patients.
Which patients are most likely to benefit from couples microbiome testing?
The highest-benefit patients are those experiencing recurrent BV (3+ episodes in 12 months), recurrent yeast infections, persistent UTIs following sex, or unexplained recurring vaginal symptoms in a monogamous relationship where standard treatment has not provided lasting relief. Couples planning conception where BV history may affect fertility outcomes are also a strong candidate group.
